Cargando…

Novel target and treatment agents for natural killer/T-cell lymphoma

The rapidly increasing use of high-throughput screening had produced a plethora of expanding knowledge on the molecular basis of natural killer/T-cell lymphoma (NKTCL), which in turn has revolutionized the treatment. Specifically, the use of asparaginase-containing regimens has led to substantial im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Xiao-Peng, Cao, Yi, Cai, Jun, Zhang, Yu-Chen, Zou, Qi-Hua, Wang, Jin-Ni, Fang, Yu, Wang, Jia-Hui, Guo, Song-Bin, Cai, Qing-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362755/ https://www.ncbi.nlm.nih.gov/pubmed/37480137 http://dx.doi.org/10.1186/s13045-023-01483-9

Ejemplares similares

Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma
por: Cai, Qingqing, et al.
Publicado: (2019)

Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma
por: Tian, Xiao-Peng, et al.
Publicado: (2023)

IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma
por: Wang, Liang, et al.
Publicado: (2018)

P1172: ARTIFICIAL INTELLIGENCE FOR PROGNOSIS PREDICTION OF NATURAL KILLER/T-CELL LYMPHOMA BASED ON MAGNETIC RESONANCE IMAGING
por: Cai, Qingqing, et al.
Publicado: (2023)

Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma
por: Peng, Yin-yin, et al.
Publicado: (2021)

Combination of Anti-PD-1 Antibody, Anlotinib and Pegaspargase “Sandwich” With Radiotherapy in Localized Natural Killer/T Cell Lymphoma
por: Sun, Peng, et al.
Publicado: (2022)

Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma
por: Peng, Rou-Jun, et al.
Publicado: (2018)

Natural killer cell homing and trafficking in tissues and tumors: from biology to application
por: Ran, Guang he, et al.
Publicado: (2022)

Red blood cell distribution width as a predictor of survival in nasal-type, extranodal natural killer/T-cell lymphoma
por: Luo, Huaichao, et al.
Publicado: (2017)

Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma
por: Huang, Jia-Jia, et al.
Publicado: (2013)

Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T‐cell lymphoma
por: Liu, Jia‐Xin, et al.
Publicado: (2023)

A Case of Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type with Dermatomyositis
por: Gong, Yu, et al.
Publicado: (2021)

BCL11A Is Oncogenic and Predicts Poor Outcomes in Natural Killer/T-Cell Lymphoma
por: Shi, Hongyun, et al.
Publicado: (2020)

Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database
por: Liu, Xin, et al.
Publicado: (2023)

Extranodal natural killer/T-cell lymphoma (nasal type) presenting as a perianal abscess: A case report
por: Liu, Yan-Ni, et al.
Publicado: (2019)

Neurolymphomatosis Caused by Nasal-type Extranodal Natural Killer/T-cell Lymphoma
por: Yi, Fang-Fang, et al.
Publicado: (2017)

T-cell dysfunction in natural killer/T-cell lymphoma
por: Feng, Xiaoyan, et al.
Publicado: (2023)

Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma
por: Li, Zhaoming, et al.
Publicado: (2019)

Prognostic significance of CD30 expression in nasal natural killer/T-cell lymphoma
por: Wang, Guan-Nan, et al.
Publicado: (2017)

Updating targets for natural killer/T-cell lymphoma immunotherapy
por: Xue, Weili, et al.
Publicado: (2021)

Prognostic impact of peripheral natural killer cells in primary central nervous system lymphoma
por: Lin, Zhiguang, et al.
Publicado: (2023)

Primary testicular natural killer/T-cell lymphoma: A CARE-case report and review of literature
por: Zhang, Wan-Lin, et al.
Publicado: (2018)

SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential
por: Xiong, Jie, et al.
Publicado: (2021)

Serum C-Reactive Protein (CRP) as a Simple and Independent Prognostic Factor in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
por: Li, Ya-Jun, et al.
Publicado: (2013)

Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type
por: Yao, Ningning, et al.
Publicado: (2020)

Primary Cutaneous Extranodal Natural Killer (NK) T-Cell Lymphoma: A Case Report
por: Zhang, Si, et al.
Publicado: (2023)

CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China
por: Feng, Yanfen, et al.
Publicado: (2017)

Radiotherapy improves survival in early stage extranodal natural killer/T cell lymphoma patients receiving asparaginase-based chemotherapy
por: Li, Yi-Yang, et al.
Publicado: (2016)

Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study
por: Li, Jia-Ying, et al.
Publicado: (2023)

Phase II Study of Gemcitabine, Peg-Asparaginase, Dexamethasone and Methotrexate Regimen for Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Final Analysis With Long-Term Follow-Up and Rational Research for the Combination
por: Wang, Yu, et al.
Publicado: (2022)

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
por: Lim, Jing Quan, et al.
Publicado: (2020)

Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
por: Cao, Yuqing, et al.
Publicado: (2020)

Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
por: Sun, Cheng, et al.
Publicado: (2015)

Extranodal natural killer/T-cell lymphoma presenting as orbital cellulitis
por: Zuhaimy, Hanis, et al.
Publicado: (2017)

Targeting Natural Killer Cells for Tumor Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

Cord-Blood Natural Killer Cell-Based Immunotherapy for Cancer
por: Zhao, Xiaoyan, et al.
Publicado: (2020)

Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group
por: Liu, Weiping, et al.
Publicado: (2021)

Epigenetic aberrations in natural killer/T-cell lymphoma: diagnostic, prognostic and therapeutic implications
por: Küçük, Can, et al.
Publicado: (2020)

Primary Natural Killer/T-Cell Lymphoma of the Ribs
por: Kim, Kyoung Min, et al.
Publicado: (2023)

High C-Reactive Protein to Albumin Ratio Predicts Inferior Clinical Outcomes in Extranodal Natural Killer T-Cell Lymphoma
por: Di, Quan-shu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_it12c5cs6tlvdrol2uofvuhpl2